Danhua Chemical Technology (600844.SH) forecasts a preloss, with an expected net loss of 307 million yuan for the year 2024.
Danhua Technology (600844.SH) released a profit warning announcement for the 2024 fiscal year, anticipating a net loss for the year.
Danhua Chemical Technology (600844.SH) has announced a forecast of a net loss of 3.07 billion yuan for the fiscal year 2024, compared to the previous year where they continued to incur losses.
The company's production and operation activities for the current year have remained stable, with product sales similar to the previous year. Preliminary statistics show that the main product, ethylene glycol, had a production of 133,000 tons and sales of 127,300 tons, with a 12.69% increase in the average annual sales price. The second product, oxalic acid, had a production of 99,300 tons and sales of 97,700 tons, with a 19.28% decrease in the average annual sales price. Ethylene glycol prices saw a slight increase during the reporting period, but oxalic acid prices decreased, resulting in overall low product prices.
Related Articles

Giant Network Group (002558.SZ) earned 1.706 billion yuan in revenue in the third quarter, with strong potential for profit release in the future.

GF Securities: MRDIMM and CXL increase AI server memory. It is recommended to pay attention to core beneficiaries in the industry chain.
.png)
NVIDIA Corporation ignites the next battlefield: Joining forces with Johnson & Johnson (JNJ.US) and Eli Lilly (LLY.US), the trillion-dollar pharmaceutical industry welcomes the revolution of "AI surgery" and "pharmaceutical factories".
Giant Network Group (002558.SZ) earned 1.706 billion yuan in revenue in the third quarter, with strong potential for profit release in the future.

GF Securities: MRDIMM and CXL increase AI server memory. It is recommended to pay attention to core beneficiaries in the industry chain.

NVIDIA Corporation ignites the next battlefield: Joining forces with Johnson & Johnson (JNJ.US) and Eli Lilly (LLY.US), the trillion-dollar pharmaceutical industry welcomes the revolution of "AI surgery" and "pharmaceutical factories".
.png)
RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


